miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.
carcinogenetic cascade
esophageal cancer
microRNAs
predictive biomarker
targeted therapy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
31 Mar 2021
31 Mar 2021
Historique:
received:
28
02
2021
revised:
26
03
2021
accepted:
29
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
11
5
2021
Statut:
epublish
Résumé
MicroRNAs (miRNAs) are small non-coding RNAs that play a pivotal role in many aspects of cell biology, including cancer development. Within esophageal cancer, miRNAs have been proved to be involved in all phases of carcinogenesis, from initiation to metastatic spread. Several miRNAs have been found to be dysregulated in esophageal premalignant lesions, namely Barrett's esophagus, Barrett's dysplasia, and squamous dysplasia. Furthermore, numerous studies have investigated the alteration in the expression levels of many oncomiRNAs and tumor suppressor miRNAs in esophageal squamous cell carcinoma and esophageal adenocarcinoma, thus proving how miRNAs are able modulate crucial regulatory pathways of cancer development. Considering these findings, miRNAs may have a role not only as a diagnostic and prognostic tool, but also as predictive biomarker of response to anti-cancer therapies and as potential therapeutic targets. This review aims to summarize several studies on the matter, focusing on the possible diagnostic-therapeutic implications.
Identifiants
pubmed: 33807389
pii: ijms22073640
doi: 10.3390/ijms22073640
pmc: PMC8037581
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
MicroRNAs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Health Ministry
ID : NET-2016-02363853
Références
J Cancer Res Clin Oncol. 2012 May;138(5):763-74
pubmed: 22270966
Oncol Rep. 2013 Mar;29(3):1115-23
pubmed: 23254782
Dis Markers. 2019 Nov 22;2019:1654780
pubmed: 31885731
Oncol Rep. 2020 May;43(5):1692-1704
pubmed: 32323857
Int J Cancer. 2014 Sep 1;135(5):1011-8
pubmed: 24166096
Biomed Pharmacother. 2019 Jun;114:108825
pubmed: 30981110
Genes (Basel). 2018 Mar 29;9(4):
pubmed: 29596364
Int J Cancer. 2011 Jan 1;128(1):132-43
pubmed: 20309880
Transl Oncol. 2021 Jan;14(1):100894
pubmed: 33069103
Cancer Sci. 2019 Apr;110(4):1140-1147
pubmed: 30729639
Cells. 2019 Aug 05;8(8):
pubmed: 31530793
Cancer Res. 2005 Aug 15;65(16):7065-70
pubmed: 16103053
Annu Rev Pathol. 2009;4:127-50
pubmed: 18767981
PLoS One. 2017 Oct 2;12(10):e0185636
pubmed: 28968424
Dis Markers. 2017;2017:8317913
pubmed: 28487599
Oncotarget. 2015 Dec 29;6(42):44422-36
pubmed: 26517243
World J Gastroenterol. 2017 Nov 21;23(43):7653-7656
pubmed: 29209106
Oncotarget. 2017 Jul 26;8(47):82991-83008
pubmed: 29137318
Oncol Lett. 2015 Jan;9(1):471-477
pubmed: 25436011
Clin Chem. 2010 Nov;56(11):1733-41
pubmed: 20847327
Mo Med. 2018 May-Jun;115(3):211-213
pubmed: 30228724
Cell Prolif. 2019 Jul;52(4):e12632
pubmed: 31094023
Biochem Biophys Res Commun. 2017 Apr 29;486(2):300-306
pubmed: 28300556
Iran Biomed J. 2018 Jun 03;22(6):367-73
pubmed: 29859516
PLoS One. 2016 Oct 4;11(10):e0164105
pubmed: 27701465
J Cell Mol Med. 2018 May 4;:
pubmed: 29726631
Mol Cancer. 2015 Feb 22;14:52
pubmed: 25743273
Oncotarget. 2018 May 11;9(36):24457-24469
pubmed: 29849953
Cancer Prev Res (Phila). 2013 Mar;6(3):196-205
pubmed: 23466817
Onco Targets Ther. 2016 May 23;9:3039-47
pubmed: 27284255
Open Med (Wars). 2016 Mar 11;11(1):31-35
pubmed: 28352763
BMC Cancer. 2018 Jun 4;18(1):631
pubmed: 29866054
Nat Methods. 2012 Jul 01;9(8):840-6
pubmed: 22751203
Springerplus. 2016 Jul 02;5(1):959
pubmed: 27386402
Int J Oncol. 2016 May;48(5):1877-85
pubmed: 26983401
PLoS One. 2020 Oct 1;15(10):e0239550
pubmed: 33002021
Oncotarget. 2014 Nov 30;5(22):11669-80
pubmed: 25375090
Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7323-7332
pubmed: 30468477
BMC Cancer. 2015 Apr 19;15:306
pubmed: 25928665
Oncol Lett. 2019 Feb;17(2):1453-1460
pubmed: 30675199
Oncogene. 2020 Feb;39(9):1983-1996
pubmed: 31772330
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28423402
Int J Clin Exp Pathol. 2017 Aug 01;10(8):8452-8460
pubmed: 31966697
Cancer Cell. 2006 Mar;9(3):189-98
pubmed: 16530703
Front Pharmacol. 2018 Dec 05;9:1421
pubmed: 30568591
Nature. 2010 Nov 25;468(7323):487
pubmed: 21107398
Molecules. 2018 Mar 29;23(4):
pubmed: 29596304
Cells. 2019 Oct 31;8(11):
pubmed: 31683698
Blood. 2009 May 28;113(22):5568-74
pubmed: 19336759
Exp Mol Med. 2019 Feb 12;51(2):1-9
pubmed: 30755582
Cells. 2020 Jan 07;9(1):
pubmed: 31936122
Oncotarget. 2017 Jan 31;8(5):8131-8142
pubmed: 28042956
Oncol Lett. 2017 Jun;13(6):4769-4775
pubmed: 28599478
Mol Med Rep. 2020 May;21(5):2073-2084
pubmed: 32323771
Thorac Cancer. 2017 Sep;8(5):501-510
pubmed: 28752530
J Cancer. 2020 Jan 1;11(6):1315-1324
pubmed: 32047538
Biomed Pharmacother. 2020 Feb;122:109696
pubmed: 31918270
Oncotarget. 2015 Oct 6;6(30):28949-60
pubmed: 26334393
Hum Pathol. 2013 Sep;44(9):1804-10
pubmed: 23618359
Int J Clin Exp Pathol. 2019 Feb 01;12(2):466-476
pubmed: 31933851
Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4532-4541
pubmed: 30058693
Am J Surg Pathol. 2016 May;40(5):e45-66
pubmed: 26813745
Int J Clin Exp Pathol. 2015 May 01;8(5):4745-54
pubmed: 26191164
Mol Carcinog. 2020 Mar;59(3):265-280
pubmed: 31867776
J Allergy Clin Immunol. 2018 Apr;141(4):1202-1207
pubmed: 29074454
Nat Rev Cancer. 2006 Apr;6(4):259-69
pubmed: 16557279
J Biol Chem. 2011 Mar 25;286(12):10725-34
pubmed: 21148309
Am J Cancer Res. 2016 Nov 01;6(11):2713-2721
pubmed: 27904783
J Cell Biochem. 2019 Dec;120(12):19345-19357
pubmed: 31464068
Int J Mol Med. 2019 Sep;44(3):973-981
pubmed: 31257524
Oncotarget. 2016 Dec 20;7(51):84508-84519
pubmed: 27811366
Cancer Res. 2002 Apr 15;62(8):2215-9
pubmed: 11956071
Int J Biochem Cell Biol. 2009 Jun;41(6):1371-80
pubmed: 19130895
Med Sci Monit. 2019 Jul 26;25:5543-5551
pubmed: 31347609
Cell. 1993 Dec 3;75(5):843-54
pubmed: 8252621
Oncotarget. 2017 Dec 14;9(2):2105-2119
pubmed: 29416757
Oncotarget. 2016 Jul 5;7(27):42805-42825
pubmed: 27081087
Exp Ther Med. 2019 Mar;17(3):1509-1516
pubmed: 30867685
Oncol Lett. 2019 Sep;18(3):2825-2834
pubmed: 31452761
Sci Rep. 2020 Nov 18;10(1):20065
pubmed: 33208781
Discov Med. 2011 Nov;12(66):371-9
pubmed: 22127108
Biomedicines. 2021 Mar 21;9(3):
pubmed: 33801049
Carcinogenesis. 2016 Sep;37(9):858-869
pubmed: 27496804
Mol Med Rep. 2015 Sep;12(3):4071-4078
pubmed: 26062578
Int J Oncol. 2016 Dec;49(6):2255-2264
pubmed: 27779648
Annu Rev Pathol. 2009;4:199-227
pubmed: 18817506
Oncotarget. 2018 Jun 19;9(47):28391-28407
pubmed: 29983868
Cell Mol Biol Lett. 2018 Mar 22;23:12
pubmed: 29588647
Am J Transl Res. 2016 Jul 15;8(7):3288-98
pubmed: 27508050
Biomed Pharmacother. 2019 Jan;109:902-909
pubmed: 30551544
Oncotarget. 2017 Jul 7;8(47):82174-82184
pubmed: 29137254
Oncol Lett. 2016 Mar;11(3):1645-1650
pubmed: 26998056
Oncotarget. 2017 Jul 25;8(30):50193-50208
pubmed: 28422730
Lancet Oncol. 2010 Feb;11(2):136-46
pubmed: 20022810
Biomed Rep. 2018 Oct;9(4):275-283
pubmed: 30233779
Nature. 2012 Feb 15;482(7385):347-55
pubmed: 22337054
J BUON. 2018 Jul-Aug;23(4):1125-1129
pubmed: 30358221
Genet Mol Res. 2015 Aug 03;14(3):8810-8
pubmed: 26345812
J Cancer. 2018 Sep 8;9(20):3660-3668
pubmed: 30405834
Int J Clin Exp Pathol. 2019 May 01;12(5):1565-1577
pubmed: 31933974
Front Endocrinol (Lausanne). 2019 Jul 02;10:430
pubmed: 31312183
Int J Clin Exp Pathol. 2015 Feb 01;8(2):1451-8
pubmed: 25973030
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92
pubmed: 16505370
J Cancer. 2020 Jun 6;11(16):4771-4782
pubmed: 32626524
Oncotarget. 2017 Jan 10;8(2):2745-2757
pubmed: 27926525
Nat Rev Genet. 2004 Jul;5(7):522-31
pubmed: 15211354
Genet Mol Res. 2016 Jun 03;15(2):
pubmed: 27323123
Int J Clin Exp Med. 2015 Sep 15;8(9):15556-62
pubmed: 26629048
Cancer Res. 2007 Jul 1;67(13):6130-5
pubmed: 17616669
Genes Dev. 2009 Jun 1;23(11):1327-37
pubmed: 19487573
Cancer. 1953 Sep;6(5):963-8
pubmed: 13094644
Onco Targets Ther. 2020 Aug 13;13:8079-8094
pubmed: 32904700
Oncotarget. 2016 Aug 9;7(32):51943-51954
pubmed: 27409164
Int J Clin Exp Pathol. 2019 Jan 01;12(1):275-281
pubmed: 31933743
Cancer Res. 2016 Jul 1;76(13):3666-70
pubmed: 27325641
Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6497-6504
pubmed: 31378889
J BUON. 2019 Mar-Apr;24(2):805-812
pubmed: 31128039
Oncotarget. 2017 Sep 23;8(49):86410-86422
pubmed: 29156804
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9
pubmed: 12434020
World J Gastroenterol. 2019 Oct 7;25(37):5604-5618
pubmed: 31602161
Exp Mol Pathol. 2014 Feb;96(1):98-107
pubmed: 24368110
World J Gastroenterol. 2011 Feb 28;17(8):1036-44
pubmed: 21448356
Front Cell Neurosci. 2013 Nov 20;7:220
pubmed: 24312010
FEBS J. 2015 Jan;282(2):224-58
pubmed: 25393971
Int J Mol Sci. 2020 Oct 30;21(21):
pubmed: 33143050
Mol Med. 2016 May 23;22:
pubmed: 27254108
Mol Cancer. 2016 Jun 29;15(1):51
pubmed: 27358073
Mediators Inflamm. 2020 Jul 26;2020:3420946
pubmed: 32774142
Am J Clin Pathol. 2017 Mar 1;147(3):301-308
pubmed: 28395057
World J Gastroenterol. 2006 Feb 7;12(5):691-6
pubmed: 16521180
Oncol Rep. 2017 Aug;38(2):725-734
pubmed: 28627653
Dis Esophagus. 2012 Apr;25(3):263-8
pubmed: 21883657
Cancer Cell Int. 2018 Nov 16;18:186
pubmed: 30479565
Biol Cell. 2018 May 28;:
pubmed: 29806708
Genet Mol Res. 2015 Jun 12;14(2):6578-82
pubmed: 26125864
Gut. 2005 Aug;54(8):1062-6
pubmed: 15857935
Int J Clin Exp Pathol. 2014 Jan 15;7(2):602-10
pubmed: 24551280
Biomed Pharmacother. 2019 Mar;111:476-484
pubmed: 30594787
World J Gastroenterol. 2011 Dec 28;17(48):5231-9
pubmed: 22219591
Mol Med Rep. 2018 Dec;18(6):5417-5426
pubmed: 30365154
Tumour Biol. 2017 Jun;39(6):1010428317705757
pubmed: 28621232
Biomolecules. 2019 Nov 22;9(12):
pubmed: 31766768
Mol Cells. 2014 Dec 31;37(12):873-80
pubmed: 25518924
Carcinogenesis. 2013 Mar;34(3):678-88
pubmed: 23172665
Oncotarget. 2016 Mar 22;7(12):15173-86
pubmed: 26959737
Pathol Res Pract. 2020 Feb;216(2):152792
pubmed: 31899048
Int J Clin Exp Med. 2015 Apr 15;8(4):4795-807
pubmed: 26131054
Sci Rep. 2017 Mar 03;7:43109
pubmed: 28256505
Cell Mol Biol Lett. 2016 Jul 28;21:3
pubmed: 28536606
Cancers (Basel). 2019 Feb 19;11(2):
pubmed: 30791487
J Int Med Res. 2017 Aug;45(4):1310-1317
pubmed: 28587538
Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1212-1220
pubmed: 30988139
Pathol Res Pract. 2020 May;216(5):152907
pubmed: 32131978
Cancer Res. 2005 Jul 15;65(14):6029-33
pubmed: 16024602
Mol Med Rep. 2019 Mar;19(3):1481-1490
pubmed: 30592263
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Med Rep. 2018 Oct;18(4):3631-3640
pubmed: 30106155
Onco Targets Ther. 2020 Aug 24;13:8463-8474
pubmed: 32943877
Theranostics. 2019 Feb 28;9(6):1599-1613
pubmed: 31037126
Asian Pac J Trop Med. 2017 May;10(5):498-502
pubmed: 28647188
PLoS One. 2012;7(1):e29551
pubmed: 22242174
Cell Death Dis. 2017 Jan 12;8(1):e2540
pubmed: 28079894
J Clin Med. 2015 Aug 21;4(8):1651-67
pubmed: 26308063
Cell Physiol Biochem. 2018;48(4):1595-1604
pubmed: 30071514
PLoS Genet. 2014 Apr 10;10(4):e1004289
pubmed: 24722255
Clin Cancer Res. 2015 Feb 15;21(4):854-63
pubmed: 25512445
Nat Rev Drug Discov. 2016 Jun;15(6):385-403
pubmed: 26775688
Int J Oncol. 2016 Jul;49(1):5-32
pubmed: 27175518
Kaohsiung J Med Sci. 2021 Mar;37(3):181-191
pubmed: 33171523
Gene. 2017 Aug 20;625:1-9
pubmed: 28476684
Clin Cancer Res. 2018 Jan 15;24(2):486-498
pubmed: 29101304
Cancer Biol Ther. 2010 Oct 1;10(7):658-64
pubmed: 20814228
Clin Transl Gastroenterol. 2013 May 16;4:e34
pubmed: 23677165
J Cancer Res Ther. 2018;14(Supplement):S132-S137
pubmed: 29578163
Cancer Res. 1999 Oct 1;59(19):4784-7
pubmed: 10519384
Mol Cell. 2013 Oct 24;52(2):157-8
pubmed: 24210173
Front Oncol. 2018 Jun 18;8:226
pubmed: 29967761
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6871-9
pubmed: 25400770
Mol Cancer. 2017 Jun 21;16(1):106
pubmed: 28633632
Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):429-37
pubmed: 26604271
Oncotarget. 2016 Feb 23;7(8):8756-70
pubmed: 26717044
EMBO J. 1998 Jan 2;17(1):149-58
pubmed: 9427749
Exp Mol Med. 2015 Sep 25;47:e185
pubmed: 26403261
Int J Biol Markers. 2019 Jun;34(2):148-155
pubmed: 30852977